traMADol
Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
---|---|---|---|---|---|---|
ConZip | CAPSULE, EXTENDED RELEASE, ORAL | 100 mg/24 hours, 200 mg/24 hours, 300 mg/24 hours | ||||
Rybix ODT | TABLET, DISINTEGRATING, ORAL | 50 mg | ||||
Ryzolt, Ultram ER | TABLET, EXTENDED RELEASE, ORAL | 100 mg/24 hours, 200 mg/24 hours, 300 mg/24 hours | ||||
Ultram | TABLET, ORAL | 50 mg |
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
traMADol (ConZip)
traMADol (Rybix ODT)
traMADol (Ryzolt, Ultram ER)
traMADol (Ultram)
traMADol (Ultram)
traMADol (Ultram)
Ultram medication guide
Ultram ER medication guide
traMADol is not to be used in children < 18 years old. Contact MD for alternative therapy.
traMADol use should be avoided in breastfeeding mothers due to possible harm to their infants.
CONZIP is classified as non-formulary, not stocked for hospital inpatient and outpatient. It is classified as formulary status for hospital clinics.
Reviewed: December 12, 2007 (traMADol ODT), and July 28, 2009 (RYZOLT), and March 28, 2006 (traMADol ER), and October 22, 2013 (CONZIP)
Update: 25 July 2017 (Pediatric update), and 24 Oct 2017 (Breastfeeding Mothers update)